نتایج جستجو برای: ژن tp53

تعداد نتایج: 23956  

Journal: :Journal of medical genetics 2010
Marielle W G Ruijs Senno Verhoef Matti A Rookus Roelof Pruntel Annemarie H van der Hout Frans B L Hogervorst I Kluijt Rolf H Sijmons Cora M Aalfs Anja Wagner Margreet G E M Ausems Nicoline Hoogerbrugge Christi J van Asperen Encarna B Gomez Garcia Hanne Meijers-Heijboer Leo P Ten Kate Fred H Menko Laura J van 't Veer

BACKGROUND Li-Fraumeni syndrome (LFS) is a rare autosomal dominant cancer predisposition syndrome. Most families fulfilling the classical diagnostic criteria harbour TP53 germline mutations. However, TP53 germline mutations may also occur in less obvious phenotypes. As a result, different criteria are in use to decide which patients qualify for TP53 mutation analysis, including the LFS, Li-Frau...

Journal: :The Journal of biological chemistry 2016
Ricardo E Perez Hong Shen Lei Duan Reuben H Kim Terresa Kim No-Hee Park Carl G Maki

p53 gene mutations are among the most common alterations in cancer. In most cases, missense mutations in one TP53 allele are followed by loss-of-heterozygosity (LOH), so tumors express only mutant p53. TP53 mutations and LOH have been linked, in many cases, with poor therapy response and worse outcome. Despite this, remarkably little is known about how TP53 point mutations are acquired, how LOH...

Journal: :Cancer research 2015
Maria Schwaederlé Vladimir Lazar Pierre Validire Johan Hansson Ludovic Lacroix Jean-Charles Soria Yudi Pawitan Razelle Kurzrock

Bevacizumab is one of the most widely used antiangiogenic drugs in oncology, but the overall beneficial effects of this VEGF-A targeting agent are relatively modest, in part due to the lack of a biomarker to select patients most likely to respond favorably. Several molecular aberrations in cancer influence angiogenesis, including mutations in the tumor suppressor gene TP53, which occur frequent...

2016
Ji-Yeon Kim Kyunghee Park Hae Hyun Jung Eunjin Lee Eun Yoon Cho Kwang Hee Lee Soo Youn Bae Se Kyung Lee Seok Won Kim Jeong Eon Lee Seok Jin Nam Jin Seok Ahn Young-Hyuck Im Yeon Hee Park

PURPOSE TP53, the most frequently mutated gene in breast cancer, is more frequently altered in HER2-enriched and basal-like breast cancer. However, no studies have clarified the role of TP53 status as a prognostic and predictive marker of triple-negative breast cancer (TNBC). MATERIALS AND METHODS We performed p53 immunohistochemistry (IHC), nCounter mRNA expression assay, and DNA sequencing ...

2016
Mohammad Reza R. Bazrafshani Pouriaali A. Nowshadi Sadegh Shirian Yahya Daneshbod Fatemeh Nabipour Maral Mokhtari Fatemehsadat Hosseini Somayeh Dehghan Abolfazl Saeedzadeh Ziba Mosayebi

Bladder cancer is a molecular disease driven by the accumulation of genetic, epigenetic, and environmental factors. The aim of this study was to detect the deletions/duplication mutations in TP53 gene exons using multiplex ligation-dependent probe amplification (MLPA) method in the patients with transitional cell carcinoma (TCC). The achieved formalin-fixed paraffin-embedded tissues from 60 pat...

Ardeshir Ghavamzadeh, Fatemeh Nevisi, Gholamreza Javadi, Hossein Pashaiefar, Kamran Alimoghaddam, Marjan Yaghmaie, Masoud Iravani,

Background: Gastric cancer (GC) is considered as one of the most common types of cancer worldwide with poor prognosis and generally limited treatment options. Recent studies have indicated that HER2, MDM2, MYC, MET, and TP53 play an important role in the development of gastric cancer. Therefore, the aim of this study was to evaluate the incidence of amplification/deletion of these genes in pati...

Journal: :Toxicological sciences : an official journal of the Society of Toxicology 2007
Michael Glei Anja Schaeferhenrich Uwe Claussen Alma Kuechler Thomas Liehr Anja Weise Brigitte Marian Wolfgang Sendt Beatrice L Pool-Zobel

Our objective was to study whether products of oxidative stress, such as hydrogen peroxide (H(2)O(2)), trans-2-hexenal, and 4-hydroxy-2-nonenal (HNE), cause DNA damage in genes, relevant for human colon cancer. For this, total DNA damage was measured in primary human colon cells and colon adenoma cells (LT97) using the single-cell gel electrophoresis assay, known as "Comet Assay." APC, KRAS, an...

2013
Bernard Leroy Jean Louis Fournier Chikashi Ishioka Paola Monti Alberto Inga Gilberto Fronza Thierry Soussi

A novel resource centre for TP53 mutations and mutants has been developed (http://p53.fr). TP53 gene dysfunction can be found in the majority of human cancer types. The potential use of TP53 mutation as a biomarker for clinical studies or exposome analysis has led to the publication of thousands of reports describing the TP53 gene status in >10,000 tumours. The UMD TP53 mutation database was cr...

Journal: :Annals of oncology : official journal of the European Society for Medical Oncology 2013
F Ganci A Sacconi N Bossel Ben-Moshe V Manciocco I Sperduti L Strigari R Covello M Benevolo E Pescarmona E Domany P Muti S Strano G Spriano G Fontemaggi G Blandino

BACKGROUND TP53 mutation is associated with decreased survival rate in head and neck squamous cell carcinoma (HNSCC) patients. We set out to identify microRNAs (miRNAs) whose expression associates with TP53 mutation and survival in HNSCC. PATIENTS AND METHODS We analyzed TP53 status by direct sequencing of exons 2 through 11 of a prospective series of 121 HNSCC samples and assessed its associ...

Journal: :Blood 2013
Yong Li Michael W Gordon Zijun Y Xu-Monette Carlo Visco Alexander Tzankov Dehui Zou Lugui Qiu Santiago Montes-Moreno Karen Dybkaer Attilio Orazi Youli Zu Govind Bhagat Kristy L Richards Eric D Hsi William W L Choi J Han van Krieken Qin Huang Weiyun Ai Maurilio Ponzoni Andrés J M Ferreri Jane N Winter Ronald S Go Miguel A Piris Michael B Møller Lin Wu Michael Wang Kenneth S Ramos L Jeffrey Medeiros Ken H Young

We identified multiple single nucleotide variants (SNVs) in the TP53 3' untranslated region (3'UTR) in tumor specimens from 244 patients with diffuse large B-cell lymphoma (DLBCL). Patients carrying a wild-type TP53 coding sequence (CDS) and 1 or more 3'UTR SNVs had a better 5-year survival rate than patients carrying a wild-type CDS and the reference 3'UTR, yet there is no statistically signif...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید